INTRODUCTION {#s1}
============

*PHIP* (MIM\# 612870) is located on 6q14.1 and encodes Pleckstrin homology domain-interacting protein (PHIP), a substrate receptor in a ubiquitin ligase pathway involved in DNA repair, genomic integrity, and cell proliferation and survival ([@MCS004200CRAC3]; [@MCS004200CRAC6]; [@MCS004200CRAC8]; [@MCS004200CRAC7]; [@MCS004200CRAC9]; [@MCS004200CRAC14]; [@MCS004200CRAC5]). A de novo likely pathogenic variant in *PHIP* was first reported in a child as part of an exome sequencing study of 100 individuals with severe intellectual disability (IQ \< 50) ([@MCS004200CRAC1]). Since then, 24 additional individuals with loss-of-function (eight nonsense, seven frameshift, three splice site, one translocation, and one gene deletion) or missense variants (*n* = 4) have been reported. The majority of these variants are de novo (*n* = 14), eight are of unknown inheritance, and one variant is inherited from an affected father to two siblings ([@MCS004200CRAC14]; [@MCS004200CRAC5]). Individuals with *PHIP* variants have a common phenotype of behavioral problems, intellectual disability/developmental delay, obesity/overweight, and dysmorphic features ([@MCS004200CRAC14]; [@MCS004200CRAC5]). Eight additional individuals were reported by [@MCS004200CRAC13] in a Chinese autism study and included one de novo likely pathogenic frameshift variant and seven inherited missense variants, but without additional phenotypic or familial data to assess whether missense variants segregated with a neurobehavioral phenotype in the family to support pathogenicity. Here, we expand our previous report ([@MCS004200CRAC14]) and describe 10 additional individuals with heterozygous predicted deleterious *PHIP* variants with symptoms consistent with previous reports of behavioral problems and/or mental health diagnoses, intellectual disability/developmental delay, obesity/overweight, and dysmorphic features. Additionally, we report a high frequency of hypotonia and constipation.

RESULTS {#s2}
=======

Molecular Findings {#s2a}
------------------

Six of the 10 variants are predicted to result in loss of function via nonsense mediated decay (four frameshift and two nonsense), one is predicted to cause abnormal splicing per Human Splicing Finder ([@MCS004200CRAC2]), and three are missense variants, each with high CADD v1.3 (Combined Annotation Dependent Depletion) scores ([Table 1](#MCS004200CRATB1){ref-type="table"}; [Fig. 1](#MCS004200CRAF1){ref-type="fig"}; [@MCS004200CRAC10]). Six of the 10 variants are de novo. Two were of uncertain inheritance because of lack of one parental sample, although the variants are not observed in the one available parent or unaffected sibling. One individual had results for neither parent, and one frameshift variant was inherited from a father whose clinical information was unavailable. Kinship analysis was performed for all tested samples, and biological parents were confirmed. None of the variants is present in population databases such as gnomAD and TOPMed. Previous genetic tests including fragile-X repeat analysis and chromosomal microarray were negative ([Supplemental Note](http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a004200/-/DC1)).

![Schematic 2D representation of the PHIP and its functional domains. Locations of likely pathogenic/pathogenic variants from previously reported individuals and the new variants reported herein indicated in bold. Schematic does not include splice site (three) or translocation (one) variants. (Adapted from [@MCS004200CRAC14].)](MCS004200Cra_F1){#MCS004200CRAF1}

###### 

Genomic findings of heterozygous *PHIP* variants

  Subject ID   Chromosome                                                      HGVS DNA reference (NM_017934.6)   HGVS protein reference (NP_060404.4)   Variant type (prediction score)^a^                        ACMG/AMP-2015 classification (criteria Met)   dbSNP/dbVar ID   Parent of origin
  ------------ --------------------------------------------------------------- ---------------------------------- -------------------------------------- --------------------------------------------------------- --------------------------------------------- ---------------- ------------------------
  1            Chr 6:79713538 (hg19) Chr6:79003821 (hg38)                      c.1562A \> G                       p.(Lys521Arg)                          Missense (CADD v1.3: 24)                                  Likely pathogenic (PS2, PM2, PP3)             Not available    De novo
  2            Chr 6:79752620 (hg19) Chr6:79042903 (hg38)                      c.540_541insA                      p.(Gly181ArgfsTer12)                   Frameshift                                                Likely pathogenic (PVS1, PM2)                 Not available    Paternal
  3            Chr 6:79735299 (hg19) Chr 6:790255582(hg38)                     c.860C \> A                        p.(Ser287Tyr)                          Missense (CADD v1.3: 24.8)                                Likely pathogenic (PM2, PS2)                  rs1085307845     De novo
  4            Chr 6:79671468 (hg19) Chr 6:78961751 (hg38)                     c.3595delG                         p.(Val1199Ter)                         Nonsense                                                  Pathogenic (PVS1, PS2, PM2)                   Not available    De novo
  5            Chr 6:79692625 (hg19) Chr 6:78982908 (hg38)                     c.2744_2747del                     p.(Lys915SerfsTer15)                   Frameshift                                                Pathogenic (PVS1, PS2, PM2)                   Not available    De novo
  6            Chr 6:79679596 (hg19) Chr 6:78969879 (hg38)                     c.3161delT                         p.(Leu1054Ter)                         Nonsense                                                  Pathogenic (PVS1, PS2, PM2)                   Not available    De novo
  7            Chr 6:79752561 (hg19) Chr 6:79042844 (hg38)                     c.598_599delACinsT                 p.(Thr200LeufsTer8)                    Frameshift                                                Likely pathogenic (PVS1, PM2)                 rs1554210073     Unknown (not paternal)
  8            Chr 6:79668186-79668189 (hg19) Chr 6:78958469-78958472 (hg38)   c.3782 + 3_3782 + 6delAAGT         IVS32 + 3_IVS32 + 6delAAGT             Splice site (HSF 3.1: most probably affecting splicing)   Variant of unknown significance (PM2)         rs1131691771     Unknown (not maternal)
  9            Chr 6:79655778 (hg19) Chr 6:78946061 (hg38)                     c.4570delT                         p.(Ser1524LeufsTer22)                  Frameshift                                                Likely pathogenic (PVS1, PM2)                 Not available    Unknown
  10           Chr 6:79735796 (hg19) Chr6:79026079 (hg38)                      c.686C \> T                        p.(Ser229Leu)                          Missense (CADD v1.3: 32)                                  Likely pathogenic (PM2, PS2)                  Not available    De novo

(HSF) Human Splicing Finder.

^a^CADD scores were only available for missense variants.

Clinical Features {#s2b}
-----------------

The 10 individuals with *PHIP* variants we describe include five females and five males, ranging from 16 mo to 15 yr of age, with an average age of 9 yr and 2 mo ([Table 2](#MCS004200CRATB2){ref-type="table"}). One individual was born prematurely, and five reported a variety of minor prenatal issues. Feeding difficulties (7/10), hypotonia (4/10), and neonatal jaundice (3/10) were the most commonly reported neonatal issues.

###### 

Clinical features of the new (*n* = 10) and previously reported cases (*n* = 24)

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  New individuals included in this report   Average for new individuals in this report   Summary of previously reported cases                                                                                                                                                                                                                                                                                                                                                                                                    
  ----------------------------------------- -------------------------------------------- -------------------------------------- ---------------------------------------------------- -------------------------------------- ----------------------------- --------------------------------- --------------------------------- ----------------------------------------------- -------------------------------------------------------- ------------------------------------------------------------ ---------------------------- --------------------------------
  Age                                       5^7/12^ yr                                   1^4/12^ yr                             15 yr                                                7^10/12^ yr                            9 yr                          12^10/12^ yr                      9^4/12^ yr                        12 yr                                           15^3/12^ yr                                              3^5/12^ yr                                                   9^2/12^ yr (16 mo-15 yr)     18 yr (5--52 yr)

  Sex                                       F                                            M                                      F                                                    F                                      F                             M                                 F                                 M                                               M                                                        M                                                            F:M = 5:5                    F:M = 14:11

  Prenatal issues                           None                                         IUGR\                                  Nuchal and arachnoid cysts (resolved in utero)\      Maternal diabetes\                     None                          None                              None                              LGA\                                            None                                                     Unilateral ureterocele                                       50%                          37.5%
                                                                                         Placental insufficiency\               LGA                                                  LGA                                                                                                                                      macrocephaly                                                                                                                                                                                       
                                                                                         Maternal hypertension                                                                                                                                                                                                                                                                                                                                                                                                                   

  Neonatal issues                           Feeding difficulty                           Feeding difficulty\                    Feeding difficulty\                                  Hypotonia\                             None                          Hypotonia                         Feeding difficulty\               Feeding difficulty\                             Feeding difficulty\                                      Feeding difficulty\                                          Feeding difficulty (70%)\    Feeding difficulty (33%)
                                                                                         GERD\                                  Jaundice                                             Lethargy\                                                                                              Jaundice                          Respiratory distress (required resuscitation)   Hypotonia                                                Hypotonia\                                                   Hypotonia (40%)              
                                                                                         PPHN of the newborn                                                                         Jaundice                                                                                                                                                                                                                                          Congenital muscular torticollis                                                           

  Developmental delay                       Yes                                          Yes                                    Yes                                                  Yes                                    Yes                           Yes                               Yes                               Yes                                             Yes                                                      Yes                                                          100%                         92%

  Age at sitting                            9 mo                                         Not achieved yet                       13 mo                                                12 mo                                  8 mo                          18 mo                             6 mo                              6.5 mo                                          9 mo                                                     20 mo                                                        11.3 mo (*n* = 9)            Not available for all patients

  Age at walking                            12 mo                                        Not achieved yet                       19 mo                                                24 mo                                  18 mo                         24 mo                             29 mo                             28 mo                                           24 mo                                                    36 mo                                                        23.8 mo (*n* = 9)            Not available for all patients

  Age at talking                            36 mo                                        9 mo                                   Normal range                                         36 mo                                  9 mo                          Normal range                      48 mo                             Delayed                                         42 mo                                                    Does not speak in sentences yet                              30 mo (*n* = 6)              Not available for all patients

  Intellectual disability                   Yes, mild & hyperlexia                       Yes                                    Yes, mild                                            Yes, mild                              Yes, mild                     Yes, mild                         Yes, mild                         Yes, mild                                       Yes, mild                                                Yes                                                          100%                         92%

  Full scale IQ                             n/a                                          n/a                                    73                                                   68                                     n/a                           60                                50-60                             n/a                                             n/a                                                      n/a                                                                                       n/a

  Vineland Overall Age (%)                  16%                                          3%                                     19%                                                  1%                                     8%                            5%                                2%                                5%                                              1%                                                       n/a                                                          6.7%                         n/a

  Communication (%)                         42%                                          9%                                     23%                                                  3%                                     8%                            14%                               2%                                4%                                              1%                                                                                                                    11.8%                        

  Daily living skills (%)                   16%                                          2%                                     50%                                                  1%                                     19%                           4%                                4%                                16%                                             1%                                                                                                                    12.6%                        

  Socialization (%)                         2%                                           12%                                    5%                                                   1%                                     5%                            5%                                2%                                5%                                              1%                                                                                                                    4.2%                         

  Motor(%)                                  50%                                          1%                                     \-                                                   2%                                     \-                            \-                                \-                                \-                                              \-                                                                                                                    18%                          

  Behavioral problems                       ASD\                                         None                                   ASD features\                                        ASD features\                          ADHD\                         ASD\                              ASD\                              ADD\                                            ASD\                                                     None                                                         88%                          84%
                                            Attention problems\                                                                 ADHD\                                                Social anxiety\                        GAD\                          ADD\                              ADHD\                             GAD/depression\                                 ADHD\                                                                                                                                              
                                            SPD                                                                                 GAD\                                                 Tantrums\                              Tantrums\                     Tantrums\                         GAD\                              Tantrums\                                       OCD\                                                                                                                                               
                                                                                                                                Tantrums\                                            Impulse problems                       Impulse problems\             Anxious in new situations         PTSD\                             Impulse problems\                               Phobias\                                                                                                                                           
                                                                                                                                Impulse problems\                                                                           SPD features                                                    Tantrums\                         SPD features                                    Tantrums\                                                                                                                                          
                                                                                                                                SPD\                                                                                                                                                        Impulse problems\                                                                 SPD features\                                                                                                                                      
                                                                                                                                Tics\                                                                                                                                                       SPD features\                                                                     Enuresis nocturna                                                                                                                                  
                                                                                                                                Trichotillomania                                                                                                                                            Tics                                                                                                                                                                                                                                 

  Sleep problems                            Yes                                          No                                     Yes                                                  No                                     No                            No                                No                                No                                              Yes                                                      No                                                           30%                          24%

  Dysmorphic features                       High forehead\                               High forehead\                         High forehead\                                       High forehead\                         High forehead\                High forehead\                    High forehead\                    Large ears\                                     Almons shaped eyes\                                      Low-set posteriorly rotated ears with thick helices\         Facial features (100%)\      Facial features (96%)\
                                            Anteverted nares\                            Almond shaped eyes\                    Synophrys\                                           Hypertelorism\                         Hypertelorism\                Synophrys\                        Large ears\                       Clinodactyly of 5^th^ finger\                   Large ears\                                              Arched eyebrows\                                             Other\                       Other\
                                            Long and smooth philtrum                     Long and smooth philtrum\              Hypertelorism\                                       Almond shaped eyes\                    Thick helices and earlobes\   Almond shaped eyes\               Thin lips\                        CAL                                             Thin lips\                                               Synophrys Full and long eyelashes\                           (60%)                        (79.2%)
                                                                                         Thin lips                              Almond shaped eyes\                                  Thick helices and earlobes\            Thin lips\                    Large ears\                       Clinodactyly of 5^th^ finger                                                      CAL                                                      Epicanthus\                                                                               
                                                                                                                                Thick helices and earlobes\                          Short nose and broad nasal tip\        Clinodactyly of 5th finger\   Anteverted nares\                                                                                                                                                            Anteverted nares\                                                                         
                                                                                                                                Anteverted nares\                                    Thin lips\                             Syndactyly of 2-3 toes        Short nose and broad nasal tip\                                                                                                                                              Long philtrum\                                                                            
                                                                                                                                Thin lips\                                           Clinodactyly Syndactyly of 2-3 toes\                                 Long and smooth philtrum                                                                                                                                                     Tongue-tie\                                                                               
                                                                                                                                Clinodactyly of 5th finger\                          CAL Hemangioma                                                                                                                                                                                                                                    Transverse palmar crease\                                                                 
                                                                                                                                CAL                                                                                                                                                                                                                                                                                                    Sacro-coccygeal dimple without medullar abnormality on MRI                                

  Neurologic problems                       None                                         Hypotonia                              Hypotonia\                                           Hypotonia\                             Truncal hypotonia\            None                              Truncal hypotonia\                Hypotonia\                                      Hypotonia\                                               Hypotonia\                                                   Hypotonia (80%)\             Hypotonia (32%)
                                                                                                                                Abnormal gait                                        Focal impaired awareness\              Extremity hypertonia                                            Hypertonia of hands               A single seizure event at 18 mo old\            Suspected seizure activity (generalized tonic-clonic)\   Febrile seizures\                                            Seizures (20%)               
                                                                                                                                                                                     Difficulty walking\                                                                                                                      Hand tremors                                    Chorea of limbs\                                         Reduced white matter volume\                                                              
                                                                                                                                                                                     Dysautonomia\                                                                                                                                                                            Migraine                                                 Cerebellar hypoplasia                                                                     
                                                                                                                                                                                     Hand tremors                                                                                                                                                                                                                                                                                                                                

  Musculoskeletal problems                  None                                         None                                   Easily fatigued Hypermobile joints                   Easily fatigued\                       Easily fatigued               Easily fatigued\                  Easily fatigued\                  Easily fatigued\                                Easily fatigued\                                         Unilateral genu recurvatum                                   Fatigue (70%)                Fatigue (40%)
                                                                                                                                                                                     Hypermobile joints                                                   Pes planus                        Pes planus                        Pes planus                                      Hypermobile joints                                                                                                                                 

  Gastrointestinal problems                 None                                         GERD (severe)                          Constipation                                         Constipation (severe)\                 Constipation\                 Constipation                      Constipation (resolved)           Constipation                                    Diarrhea Constipation\                                   None                                                         Constipation (70%)\          Constipation(8%)\
                                                                                                                                                                                     GERD                                   GERD                                                                                                                                              GERD                                                                                                                  GERD (40%)                   GERD (4%)

  Endocrine problems                        None                                         Subclinical hypothyroidism             Borderline overweight (BMI = 23.9, *z*-score = 1)\   Obesity (BMI = 30.6, z-score = 2.71)   None                          Unilateral cryptorchidism         Recent rapid weight gain          None                                            Overweight (BMI = 23.9, *z*-score = 1.09)                None                                                         Obesity/ overweight (30%)\   Obesity (76%)\
                                                                                                                                Delayed bone age\                                                                                                                                                                                                                                                                                                                                                   Other (30%)                  Other (16.7%)
                                                                                                                                Delayed menarche                                                                                                                                                                                                                                                                                                                                                                                 

  Eye problems                              None                                         Pale optic nerve                       Convergence problems                                 Amblyopia\                             Convergence problems          Amblyopia\                        Myopia\                           None                                            Severe visual impairment\                                Myopia\                                                      80%                          72%
                                                                                                                                                                                     Myopia                                                               Myopia                            Astigmatism\                                                                      Unilateral legally blind\                                Strabismus                                                                                
                                                                                                                                                                                                                                                                                            Alternating exotropia/amblyopia                                                   Amblyopia                                                                                                                                          

  Infectious problems                       None                                         None                                   None                                                 Otitis media\                          None                          None                              UTI                               Otitis media\                                   Otitis media\                                            UTI                                                          50%                          24%
                                                                                                                                                                                     Upper respiratory                                                                                                                        Upper respiratory                               Upper respiratory TI                                                                                                                               
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\(F\) Female, (M) male, (n/a) not available, (IUGR) intrauterine growth restriction, (PPHN) persistent pulmonary hypertension in the neonate, (GERD) gastroesophageal reflux disease, (LD) learning disability, (ASD) autism spectrum disorder, (SPD) sensory processing disorder, (ADHD/ADD) attention deficit (hyperactivity) disorder, (GAD) generalized anxiety disorder, (PTSD) posttraumatic stress disorder, (BMI) body mass index, (OM) otitis media, (UTI) urinary tract infection, (CAL) café au lait macule.

All individuals had delayed developmental milestones, and the majority were diagnosed with intellectual disability and/or learning disability ([Table 2](#MCS004200CRATB2){ref-type="table"}; [Supplemental Note](http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a004200/-/DC1); [Supplemental Table S1](http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a004200/-/DC1)). The average ages for major developmental milestones were 11.3 mo for sitting (*n* = 9), 23.8 mo for walking (*n* = 9), and 30 mo for talking (*n* = 6). All individuals have intellectual disability (ID) or developmental delay (10/10), which is generally mild (IQ: 60--70) and in several cases was associated with higher verbal than performance IQ.

On the Vineland-II assessment of adaptive behaviors (*n* = 9), age-adjusted percentiles varied in communication (1%--42%; average:11.8%, median: 8%) and daily living skills (1%--50%; average: 12.6%, median 4%). Three children were in an appropriate age range for motor domain assessment, although there was a significance range of scores (1%--50%; average: 17.6%, median: 2%). However, all individuals had low socialization scores (1%--12%; average: 4.2%, median: 5%) and low overall composite scores (1%--19%; average: 6.7%, median 5%). Most individuals had behavioral diagnoses and/or significant behavioral challenges (8/9). The most common behavioral issues were attention-deficit/hyperactivity disorder (ADHD), attention deficit disorder (ADD) or attention span problems (7/9), anxiety and/or depression (7/9), aggression or tantrums (7/9), autism or features of autism spectrum disorder (ASD) (6/9), and impulse control problems (5/9). Sensory processing disorder (SPD) or similar symptoms were also common (7/9) and overlapped with autism or ASD features in 5/7 cases. Additionally, trichotillomania, emotional lability, fear of new situations, posttraumatic stress disorder (PTSD), and obsessive--compulsive disorder (OCD) were each noted in a single individual, and two individuals had a tic disorder. Sleep issues were noted in three individuals. Movement disorders included hand tremors in two individuals and chorea in another. Movement issues have worsened with age for two individuals.

Seizure or suspected seizure activity were observed in four individuals. One individual has complex partial seizures (focal impaired awareness), diagnosed at age 6 yr with a frequency of two to three episodes per day prior to medication. She has abnormal EEG (background slowing) and suspected absence seizures. One individual has suspected generalized tonic clonic seizure activity with approximately three seizures per year since age 11; however, 30-min EEGs were normal, and he has not been treated with medication. One individual had five episodes of febrile seizures before age 4. Another individual had a seizure at 18 mo old, but had normal EEGs and no further seizure activity.

All individuals have some dysmorphic features (10/10). The most common facial features were thick helices and earlobes/larger ears (8/10), high forehead (7/10), thin lips (6/10), almond shaped eyes (5/10), large ears (4/10), anteverted nares (4/10), and long and smooth philtrum (4/10). Hypertelorism (3/10), synophrys (3/10), short nose and broad nasal tip (2/10), and epicanthal folds (1/10) were less commonly noted. Other features included clinodactyly of the fifth finger (5/10), café-au-lait spots (4/10), and two-three toe syndactyly (2/10) ([Table 2](#MCS004200CRATB2){ref-type="table"}; [Supplemental Table S1](http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a004200/-/DC1)).

Most individuals have less severe medical issues compared to their neurodevelopmental and behavioral manifestations. Despite the previously reported association with obesity, only two individuals in this series were obese or overweight. Notably, one individual was borderline normal/overweight and another was within normal range but had recent rapid weight gain.

The majority of individuals (9/10) were hypotonic and/or fatigued easily. Some individuals were able to participate in age-appropriate motor activities (i.e., outdoor games and sports) with limited restriction, whereas others had more severe motor impairment.

Gastrointestinal problems were also commonly reported, primarily chronic constipation (7/10) and gastroesophageal reflux disease (GERD) (4/10). In some cases, these gastrointestinal issues were severe with four individuals requiring daily laxatives and one requiring a cecostomy tube. One individual had such severe reflux and feeding difficulties from birth that he still primarily feeds through a NG tube at 16 mo old.

Additionally, ophthalmologic problems were common (8/10); most commonly amblyopia (4/10) and also myopia, astigmatism, and convergence disorder. Strabismus was reported in a single individual. Several individuals (5/10) had recurrent infections including upper respiratory infections, otitis media, and urinary tract infections, although none were diagnosed with an immunodeficiency, and there were no atypical infections. Hypermobile joints and pes planus were each separately observed in 3/10 individuals. One of them is severely affected with chronic joint pain, and clinical diagnosis of hypermobile Ehlers--Danlos syndrome was made although no variants have been identified in genes known to be associated with Ehlers--Danlos syndrome. Endocrine problems other than obesity/overweight were infrequent (3/10) and included subclinical hypothyroidism, delayed menarche, and delayed bone age (2 yr). One individual had unilateral crypthorchidism.

DISCUSSION {#s3}
==========

We report 10 new individuals with *PHIP* variants with a clinical phenotype consistent with previously reported *PHIP*-related phenotype. The neurodevelopmental and behavioral phenotype of our newly reported individuals is similar to that in previous reports and represents the major challenge for these individuals ([@MCS004200CRAC14]; [@MCS004200CRAC5]). Most individuals have borderline intellectual disability and fluent speech. We identified specific deficits in social skills as well as a high frequency of ADHD or attention problems, anxiety, depression, sensory processing disorder, aggressive tantrums, autism or ASD features, and impulse control problems. Many individuals had multiple behavioral issues.

Individuals in our cohort also share the common dysmorphic features with previously reported individuals. Other common medical problems associated with *PHIP* variants are ophthalmologic problems, hypotonia, easy fatiguability, gastrointestinal problems including constipation and reflux, hypermobile joints, recurrent minor infections, sleeping problems, and neonatal feeding difficulty. In many cases, these symptoms significantly impact daily life and require medical interventions ([Fig. 2](#MCS004200CRAF2){ref-type="fig"}; [Supplemental Table S1](http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a004200/-/DC1)).

![Heatmap of most commonly seen clinical findings in at least one study among all reported individuals by this study, [@MCS004200CRAC14], and [@MCS004200CRAC5]. To emphasize the most commonly observed clinical findings within the cohorts and differences/similarities on the frequencies of some clinical findings between two cohorts, we created the heatmap of the findings by comparing the observed ratio of findings within each group for this study and [@MCS004200CRAC5]. For [@MCS004200CRAC14] individuals, a binary comparison is used because of the small number of individuals. Further clinical details are provided in [Supplemental Table S1](http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a004200/-/DC1).](MCS004200Cra_F2){#MCS004200CRAF2}

The two most notable differences between our cohort and previously reported individuals were the presence of significant gastrointestinal issues and relatively lower frequency of obesity in our series ([Table 2](#MCS004200CRATB2){ref-type="table"}; [Fig. 2](#MCS004200CRAF2){ref-type="fig"}). In our cases, constipation (7/10), gastrointestinal reflux (4/10), and infant feeding problems (7/10) were common and, in some cases, severe. These symptoms were infrequently reported in previously reported cases: constipation (2/25), gastrointestinal reflux (1/25), and infant feeding problems (6/25). This difference could reflect absence of gastrointestinal data for other cohorts or a range of symptoms and symptom severity. Additionally, in previously reported cases, 75% were obese or overweight, whereas only three individuals (30%) in our cohort were obese or overweight. However, the average age of all previously reported obese/overweight individuals was 20.8 ± 13.5 (median = 15 yr) years, whereas individuals in this report had a mean age of 9.2 ± 4.7 (median = 9.25 yr) years. Weight gain seems to increase with puberty, and obesity tends to be abdominal. This could provide an opportunity to intervene before weight gain becomes significant through diet, exercise, and possibly medication.

*PHIP* was previously reported to encode multiple alternative isoforms ([@MCS004200CRAC9]; [@MCS004200CRAC14]; [@MCS004200CRAC5]) probably because of different nomenclature used by different groups: NDRP by [@MCS004200CRAC6], PHIP short isoform by [@MCS004200CRAC3], and long isoform (PHIP1) by [@MCS004200CRAC9]. The long isoform (1821-amino-acid-long) isolated by [@MCS004200CRAC9] seems to be the only protein product of *PHIP*. There are no recurrent variants or mutational hotspots in the protein. So far there is no phenotypic difference between missense and loss-of-function variants. Furthermore, although dysmorphic facial features are commonly reported across all individuals, there were no facial features specific to this condition that were recognizable.

PHIP is also known as DCAF14 (DDB1- and CUL4-associated factor 14) and is thought to assist in the binding of the ubiquitin complex to the target protein as a substrate receptor for the ubiquitin ligase complex that regulates cellular processes such as cell proliferation and survival, genomic integrity, and DNA repair ([@MCS004200CRAC8]; [@MCS004200CRAC7]; [@MCS004200CRAC14]). The PHIP protein has several known functional domains including a WD40 repeat domain, a pleckstrin homology domain binding region, nuclear localization signals, and bromodomains ([Fig. 1](#MCS004200CRAF1){ref-type="fig"}; [@MCS004200CRAC3]; [@MCS004200CRAC6]; [@MCS004200CRAC9]; [@MCS004200CRAC4]). The PHIP WD40 region is likely involved in substrate binding and a recent study demonstrates that loss of the WD40 region prevents CUL4 recruitment to chromatin in the early stages of the cell cycle ([@MCS004200CRAC4]). They also showed that depletion of PHIP caused accumulation of some of the CUL4/DDB1 ubiquitin ligase products, including CDT1, p21, and SET8, on chromatin and results in abnormal cell cycle progression, genomic instability, and rereplication of genetic information ([@MCS004200CRAC4]). In addition, loss-of-function variants in *CUL4B*, a gene encoding a protein in the same functional pathway, are associated with an overlapping phenotype of intellectual disability, behavioral problems, and obesity ([@MCS004200CRAC12]). The three missense variants in our cohort all fall in the WD40 domain that is expected to be intolerant to variation ([@MCS004200CRAC04]). Moreover, gnomAD constraint metrics for missense (*Z*-score = 5.14) and loss-of-function (pLI = 1, o/e = 0.6) variants are in favor of intolerance to variation ([@MCS004200CRAC06] ). In mice, *Phip* is ubiquitously expressed and is expressed at high levels in skeletal muscle, brain, and pancreatic islet cells, consistent with the most common symptoms of *PHIP*-related phenotype such as hypotonia, neurobehavioral issues, and obesity ([@MCS004200CRAC9]).

The OMIM entry for *PHIP*-related phenotype (MIM\# 617991) lists the acronym DIDOD (developmental delay, intellectual disability, obesity, and dysmorphic features). As behavioral problems are also among the most prominent and challenging problems in individuals with pathogenic *PHIP* variants, we propose to add "behavioral problems"; hence, the acronym BIDOD (behavioral problems, intellectual disability/developmental delay, obesity/overweight, and dysmorphic features) syndrome for *PHIP*-related phenotype.

In summary, the additional individuals we report are consistent with the phenotypic spectrum of previously reported individuals with *PHIP*-related BIDOD syndrome with the exception of higher frequency of gastrointestinal problems and an age-dependent relatively lower frequency of obesity/overweight during early childhood. Because the *PHIP*-related BIDOD syndrome is a relatively newly identified condition, more longitudinal phenotypic data are needed to further clarify the natural history and identify the most effective methods for symptom management.

METHODS {#s4}
=======

This study was approved by the Columbia University Institutional Review Board (Protocol No: IRB-AAAJ8651), and signed informed consents were obtained from participants. Participants who were clinically diagnosed contacted us to participate in our natural history study of individuals with predicted pathogenic/likely pathogenic *PHIP* variants. All participants had clinical exome sequencing or clinical panel gene testing because of behavioral problems and/or intellectual disability/developmental delay. None of the 10 individuals included has been previously reported in the literature. Clinical genetic test reports were reviewed, and all *PHIP* variants were classified according to the ACMG 2015 variant classification guidelines ([Table 1](#MCS004200CRATB1){ref-type="table"}; [@MCS004200CRAC11]). Medical records were reviewed, primary care takers were interviewed by telephone about the proband\'s medical history when possible, and adaptive development was assessed in nine individuals using the Vineland-II Adaptive Behavior Scales. Facial features were summarized after reviewing photographs, but only two families gave consent for publication of photos ([Table 2](#MCS004200CRATB2){ref-type="table"}; [Fig. 3](#MCS004200CRAF3){ref-type="fig"}; [Supplemental Note](http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a004200/-/DC1)).

![Facial photos of the individuals 10 (*left*) and 4 (*right*) at 3 and 7.5 yr old, respectively.](MCS004200Cra_F3){#MCS004200CRAF3}
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Data Deposition and Access {#s5a}
--------------------------

All reported variants, along with associated human phenotype ontology terms, are submitted to ClinVar (<https://ncbi.nlm.nih.gov/clinvar/>) under accession numbers SCV000899256.1 (p.Ser28Tyr), SCV000899257.1 (p.Thr200LeufsTer8), SCV000899258.1 (IVS32 + 3_IVS32 + 6delAAGT), SCV000899259.1 (p.Val1199Ter), SCV000899260.1 (p.Gly181ArgfsTer12), SCV000899261.1 (p.Ser1524LeufsTer22), SCV000899262.1 (p.Lys915SerfsTer15), SCV000899263.1 (p.Lys521Arg), SCV000899264.1 (p.Leu1054Ter), and SCV000899265.1 (p.Ser229Leu).
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